Prostate Cancer News Archive: 30-Nov-2005

• Low PSA may not rule out prostate cancer (Reuters via Yahoo! News)
  Even if patients have relatively low prostate specific antigen (PSA) levels, a biological marker for the disease, abnormalities detected by digital rectal examination (DRE) can help identify prostate cancer, re-enforcing the importance of this procedure, new study findings suggest.



• New treatment helps prostate cancer patients (News 14 Carolina)
  (DURHAM) -- Every year, prostate cancer kills more than 30,000 men. The American Cancer Society estimates that one in six men will get the disease in their life time.



• Cellular molecule spurs growth of prostate cancer (EurekAlert!)
  CHAPEL HILL ? University of North Carolina at Chapel Hill scientists have identified a molecule that stimulates the aggressive growth of prostate cancer.



• Molecule identified in prostate cancer (UPI)
  CHAPEL HILL, N.C., Nov. 29 (UPI) -- University of North Carolina at Chapel Hill researchers say they have identified a molecule that stimulates the aggressive growth of prostate cancer.



• Long-term hormone therapy best for prostate cancer (Reuters)
  Androgen deprivation therapy involves lowering levels of male hormones, such as testosterone, in the body in an effort to block or slow the growth of prostate cancer. Androgen deprivation therapy is most commonly achieved with medications, but it can also be produced by removing the testes.

Back to Prostate Cancer News Archives